Processa Pharmaceuticals, Inc. Operating Lease, Expense
Processa Pharmaceuticals, Inc. (PCSA) reported Operating Lease, Expense of $42.67 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-08-13
- Processa Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2024-06-30 was $21.30K, a 5.53% increase year-over-year.
- Processa Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2024-03-31 was $21.37K, a 7.94% increase year-over-year.
- Processa Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2023-12-31 was $20.98K, a 8.18% increase year-over-year.
- Processa Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2023-09-30 was $20.57K, a 1.27% decline year-over-year.
- Processa Pharmaceuticals, Inc. operating lease, expense for fiscal 2023 was $81.53K, a 4.66% decline from fiscal 2022.
- Processa Pharmaceuticals, Inc. operating lease, expense for fiscal 2022 was $85.52K, a 1.35% increase from fiscal 2021.
- Processa Pharmaceuticals, Inc. operating lease, expense for fiscal 2021 was $84.38K, a 7.78% increase from fiscal 2020.
- Processa Pharmaceuticals, Inc. operating lease, expense for fiscal 2020 was $78.29K, a 5.62% increase from fiscal 2019.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $21.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $42.67K 10-Q · filed 2024-08-13 | $63.65K derived: sum of 3 quarters · filed 2024-08-13 | $84.22K derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | $21.37K 10-Q · filed 2024-05-10 | $42.35K derived: sum of 2 quarters · filed 2024-05-10 | $62.92K derived: sum of 3 quarters · filed 2024-05-10 | $83.10K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-12-31 | $20.98K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $41.55K derived: sum of 2 quarters · filed 2024-03-29 | $61.73K derived: sum of 3 quarters · filed 2024-08-13 | $81.53K 10-K · filed 2024-03-29 |
| 2023-09-30 | $20.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $40.75K derived: sum of 2 quarters · filed 2024-08-13 | $60.55K 10-Q · filed 2023-11-13 | $79.94K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-06-30 | $20.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $39.98K 10-Q · filed 2024-08-13 | $59.37K derived: sum of 3 quarters · filed 2024-08-13 | $80.21K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $19.80K 10-Q · filed 2024-05-10 | $39.19K derived: sum of 2 quarters · filed 2024-05-10 | $60.03K derived: sum of 3 quarters · filed 2024-05-10 | $82.76K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $19.39K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $40.23K derived: sum of 2 quarters · filed 2024-03-29 | $62.96K derived: sum of 3 quarters · filed 2024-03-29 | $85.52K 10-K · filed 2024-03-29 |
| 2022-09-30 | $20.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $43.57K derived: sum of 2 quarters · filed 2023-11-13 | $66.13K 10-Q · filed 2023-11-13 | $87.88K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $22.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $45.29K 10-Q · filed 2023-08-10 | $67.04K derived: sum of 3 quarters · filed 2023-08-10 | $88.35K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $22.56K 10-Q · filed 2023-05-15 | $44.31K derived: sum of 2 quarters · filed 2023-05-15 | $65.61K derived: sum of 3 quarters · filed 2023-05-15 | $86.49K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $21.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $43.05K derived: sum of 2 quarters · filed 2023-03-30 | $63.93K derived: sum of 3 quarters · filed 2023-03-30 | $84.38K 10-K · filed 2023-03-30 |
| 2021-09-30 | $21.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $42.17K derived: sum of 2 quarters · filed 2022-11-08 | $62.62K 10-Q · filed 2022-11-08 | $81.04K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $20.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $41.32K 10-Q · filed 2022-08-11 | $59.73K derived: sum of 3 quarters · filed 2022-08-11 | $80.13K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $20.45K 10-Q · filed 2022-05-12 | $38.86K derived: sum of 2 quarters · filed 2022-05-12 | $59.26K derived: sum of 3 quarters · filed 2022-05-12 | $79.19K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $18.41K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $38.80K derived: sum of 2 quarters · filed 2022-03-30 | $58.74K derived: sum of 3 quarters · filed 2022-03-30 | $78.29K 10-K · filed 2022-03-30 |
| 2020-09-30 | $20.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $40.33K derived: sum of 2 quarters · filed 2021-11-12 | $59.88K 10-Q · filed 2021-11-12 | $78.99K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $19.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $39.48K 10-Q · filed 2021-08-12 | $58.59K derived: sum of 3 quarters · filed 2021-08-12 | $77.33K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $19.55K 10-Q · filed 2021-05-13 | $38.66K derived: sum of 2 quarters · filed 2021-05-13 | $57.39K derived: sum of 3 quarters · filed 2021-05-13 | $75.72K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $19.11K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $37.84K derived: sum of 2 quarters · filed 2021-03-25 | $56.18K derived: sum of 3 quarters · filed 2021-03-25 | $74.12K 10-K · filed 2021-03-25 |
| 2019-09-30 | $18.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $37.06K derived: sum of 2 quarters · filed 2020-11-12 | $55.01K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $18.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $36.28K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $17.95K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |